Michael Gelband’s Accendra Health ACH Stock Holding History

Michael Gelband’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-206,933	Closed	-$993K	–	1926
2025 Q3	$993K	Buy	+206,933	New	+$1.32M	0.01%	962
2024 Q4	–	Sell	-26,801	Closed	-$421K	–	1902
2024 Q3	$421K	Buy	+26,801	New	+$406K	﹤0.01%	1255
2023 Q3	–	Sell	-17,891	Closed	-$341K	–	2012
2023 Q2	$341K	Buy	+17,891	New	+$319K	﹤0.01%	1487
2020 Q2	–	Sell	-12,156	Closed	-$111K	–	1951
2020 Q1	$111K	Buy	+12,156	New	+$73.4K	0.01%	878

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Michael Gelband's ACH Position: Q4 2025 in Review

Michael Gelband sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 206,933 shares — an estimated $993K sold.

Michael Gelband first reported a position in ACH in Q1 2020 and held it in 4 quarters. The position peaked at $993K in Q3 2025. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

Michael Gelband reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 206,933 Accendra Health shares in Q4 2025, an estimated $993K.
Michael Gelband first reported a position in Accendra Health in Q1 2020 and held it in 4 quarters.
Michael Gelband's Accendra Health position peaked at $993K in Q3 2025.
168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.